An expert panel has recommended suspending ranitidine after tests found cancer-linked NDMA levels in half the samples, bringing India closer to a nationwide ban
Divi's Labs stock was quoting at ₹5,855.50, up 3.81 per cent from Thursday, April 17 close of ₹5,640
Administering the right dose for asset-light expansion and steady margins
To commercialise transcatheter aortic valve system in India, Europe and other select markets
Indian firms have been focusing on complex generics for some time now, which insulates them partially from pricing pressures in the generics space in the US
Nuvama Institutional Equities said therapies like antidiabetic, anti-infective and respiratory had underperformed in the Indian pharma market
Growth hormone kicks in as India's largest pharma firm's vital signs hold amid generic strain
A Russian missile struck a warehouse of an Indian pharmaceutical company in Ukraine on Saturday, the Ukrainian embassy in India said. In a social media post, the mission alleged that Moscow is deliberately targeting Indian businesses, destroying medicines meant for children and the elderly. "Today, a Russian missile struck the warehouse of Indian pharmaceutical company Kusum in Ukraine," the Ukrainian embassy said. "While claiming "special friendship" with India, Moscow deliberately targets Indian businesses -? destroying medicines meant for children and the elderly," it posted on X. No further details are immediately available.
According to market estimates, Leqselvi is projected to contribute $90 million to Sun Pharma's sales in FY26, and $125 million in FY27
However, on a weekly basis, the Sensex and Nifty posted a decline of 0.27 per cent and 0.33 per cent, respectively
Banking, financial services, and insurance (BFSI), telecom, and metals saw the highest FII flows in March 2025
The rise in the Biocon share price came after its wholly-owned unit, Biocon Pharma, received USFDA nod for Everolimus tablets.
Cipla said USFDA has approved the ANDA submitted for Paclitaxel Protein-bound Particles for Injectable Suspension (albumin-bound), 100 mg/vial, Single-Dose Vial ('Protein-bound Paclitaxel') on Apr 10
The rise in the Sun Pharma share price came after a favourable ruling from a US court regarding its planned launch of Leqselvi (deuruxolitinib).
The AEO programme is implemented by the Central Board of Indirect Taxes and Customs (CBIC) under the aegis of the World Customs Organization's SAFE Framework
Technical charts hint that pharma shares such as Cipla, Lupin, Sun Pharma, Zydus Lifesciences and Gland Pharma could slide up to 23% as Trump tariff threat on pharma import looms.
Augmentin remains top-selling medicine brand at Rs 816 crore sales
The fall in Dr. Reddy's share price came after the company announced that it received approximately Rs 2,395-crore show cause notice from I-T department
Brokerages also felt that the pharma companies will aim to pass on the tariff hike to payors
Companies such as Sun Pharma which have a significant specialty portfolio could be less impacted than Indian peers in the US market given lower competition in niche segments